Skip to main content

Year: 2025

HUB Cyber Security Announces Deepening of Engagement With Leading European Financial Institution

TEL AVIV, Israel, Dec. 11, 2025 (GLOBE NEWSWIRE) — HUB Cyber Security Ltd. (Nasdaq: HUBC) (“HUB” or the “Company”), a global leader in confidential computing and secured data fabric technologies, today announced that it has expanded its long-standing relationship with a major European financial institution, adding new cybersecurity assessment and consultancy services to an existing multi-year engagement. Under the expanded scope, HUB will deliver application security testing, including mobile-application penetration testing and code-review services. The expansion reflects the client’s continued confidence in HUB’s capabilities and supports ongoing digital risk and compliance initiatives. This engagement aligns with HUB’s broader go-to-market activities in Europe, where the Company is expanding its portfolio of security, compliance...

Continue reading

PharmaCorp Enters Letter of Intent for the Acquisition of Pharmacy Files in Western Canada

SASKATOON, Saskatchewan, Dec. 11, 2025 (GLOBE NEWSWIRE) — PHARMACORP RX INC. (“PharmaCorp” or the “Corporation”) (TSXV: PCRX) is pleased to announce that it has entered into a non-binding letter of intent (“LOI”) to acquire from an arm’s length vendor (the “Vendor”) the prescription files, patient records, and related operational data (the “Pharmacy Files”) of a pharmacy located in the same community as one of PharmaCorp’s existing PharmaChoice-bannered pharmacies in Western Canada (the “Proposed Acquisition”). The purchase price for the Proposed Acquisition is anticipated to be $350,000 subject to customary adjustments. The Proposed Acquisition will be satisfied with cash on hand with closing expected to occur during the first quarter of 2026. No finder’s fees are payable in respect of the Proposed Acquisition. The Proposed Acquisition...

Continue reading

Spectrotel Completes Acquisition of Mosaic NetworX

NEPTUNE, N.J., Dec. 11, 2025 (GLOBE NEWSWIRE) — Spectrotel, Inc., a leading provider of Managed Network Services and Connectivity solutions, today announced the official closing of its acquisition of Mosaic NetworX, a premier global managed services provider. The closing follows the definitive agreement announced on September 17, 2025. Finalizing the acquisition strengthens Spectrotel’s ability to support mid-market and enterprise customers with secure, scalable managed network solutions, particularly across distributed and international environments. Mosaic brings deep expertise in SASE and SD-WAN architectures that will further enhance Spectrotel’s service delivery and engineering capabilities. “We’re excited to officially welcome Mosaic to the Spectrotel team,” said Ross Artale, CEO of Spectrotel. “Their experience with global...

Continue reading

Galway Metals Announces Closing of Private Placement

TORONTO, Dec. 11, 2025 (GLOBE NEWSWIRE) — Galway Metals Inc. (TSXV: GWM) (“Galway” or the “Corporation”) is pleased to announce that it has closed its previously announced non-brokered private placement (the “Private Placement”) consisting of 855,370 units of the Corporation (“Units”) at a price of $0.54 per Unit for aggregate gross proceeds to the Corporation of $461,899.80. Each Unit consists of one common share of the Corporation, and one half of one transferable common share purchase warrant (a “Warrant”). Each Warrant will entitle the holder to acquire one common share of the Corporation for an exercise price of $0.80 per share for a period of 3 years from the closing date of the Private Placement. In connection with the closing of the Private Placement, one arm’s-length finder will receive an aggregate of $13,859.10 cash...

Continue reading

AB Science announces new publication on Medrxiv highlighting clinical benefit with masitinib in Amyotrophic Lateral Sclerosis patients prior any complete loss of function

PRESS RELEASE AB SCIENCE ANNOUNCES NEW PUBLICATION ON MEDRXIV HIGHLIGHTING CLINICAL BENEFIT WITH MASITINIB IN AMYOTROPHIC LATERAL SCLEROSIS PATIENTS PRIOR ANY COMPLETE LOSS OF FUNCTIONSignificant improvement in functional decline measured by the ALSFRS-R score, with a 4.04-point difference favoring masitinib over placebo (p=0.0065) Significant benefit on CAFS (relative benefit +20.2%, p=0.0290) Median progression-free survival (PFS) extended by 9 months (p=0.0057) Median overall survival (OS) increased by 12 months (p=0.0192)THESE RESULTS INFORMED THE DESIGN OF CONFIRMATORY STUDY AB23005, TARGETING PATIENTS PRIOR ANY COMPLETE LOSS OF FUNCTION TO OPTIMIZE THE BENEFIT-RISK BALANCE AND ENHANCE THE LIKELIHOOD OF STUDY SUCCESS Paris, December 11, 2025, 6.30pm CET AB Science SA (Euronext – FR0010557264 – AB) today announced...

Continue reading

REXEL: Statement relating to the total number of shares and voting rights as of November 30, 2025

Rexel: Statement relating to the total number of shares and voting rights pursuant to Article L.233-8 II of the French Commercial Code and Article 223-16 of the General Rules of the French Autorité des marchés financiersDate Number of shares Number of voting rights2025-11-30 299,036,619 Theoretical number of voting rights(1): 299,036,619Exercisable number of voting rights(2): 293,849,850  (1)         Number of voting rights including treasury shares deprived from voting rights.(2)         Number of voting rights excluding treasury shares deprived from voting rights.AttachmentStatement relating to the total number of shares and voting rights as of November 30, 2025

Continue reading

Aramis Group – Alejandro Garcia Mella appointed CEO at Clicars (Spain)

 PRESS RELEASE Arcueil, December 11, 2025 Alejandro Garcia Mella appointed Chief Executive Officer at Clicars, Aramis Group’s Spanish entity Aramis Group announces the appointment of Alejandro Garcia Mella as Chief Executive Officer at Clicars. He succeeds José Carlos del Valle, who is now pursuing a new professional project. With over 15 years of experience within the organization, Alejandro Garcia has contributed decisively to the Group’s growth across all its geographies. His proven expertise, in-depth knowledge of markets and operations, and mastery of the business model have played a key role in the Group’s major structuring milestones. Alejandro notably served as Purchasing Director for Aramisauto in France, then at Group level. Since March 2025, as Chief Revenue Officer (CRO), he has supported all of the Group’s...

Continue reading

BPCE and Generali jointly agree to end negotiations related to the establishment of a Joint Venture in Asset Management

BPCE and Generali jointly agree to end negotiations related to the establishment of a Joint Venture in Asset Management Paris-Milan, 12 11 2025 Following the announcement on 21 January 2025 of the signature of a non-binding Memorandum of Understanding (“MoU”) to create a joint venture between their respective asset management operations, Generali and BPCE carried out extensive discussions and applicable consultation processes with relevant stakeholders, in line with the respective parties’ processes and governance frameworks. While the work conducted together in recent months confirmed the merits and industrial value of a partnership, Generali and BPCE have jointly taken the decision to terminate negotiations, in line with the terms communicated on 15 September, concluding that the conditions to reach a final agreement are not currently...

Continue reading

Voltalia awarded 68 megawatts in Italy through FERX auction

Voltalia awarded 68 megawatts in Italy through FERX auction Voltalia (Euronext Paris, ISIN code: FR0011995588), an international player in renewable energies, announces securing 20 years tariff for 68 megawatts solar projects in Italy Voltalia Italy established in Milan since 2019 and in Agrigento since 2022, with a solar and storage pipeline of more than 500 megawatts, takes a new step with four projects selected in FERX tariff auction, strengthening its role in the development of renewable energy in Italy. The company owns more than 100 megawatts authorized, out of which 68 megawatts now benefit of 20 years index tariff, that will ensure stable revenues for the next years. These future solar plants will generate an amount of energy equivalent to the annual consumption of more than 110,499 inhabitants and will prevent the emission of...

Continue reading

Mortgage Rates Remain Near 2025 Lows

Primary Mortgage Market Survey®U.S. weekly average mortgage rates as of 12/11/2025MCLEAN, Va., Dec. 11, 2025 (GLOBE NEWSWIRE) — Freddie Mac (OTCQB: FMCC) today released the results of its Primary Mortgage Market Survey® (PMMS®), showing the 30-year fixed-rate mortgage (FRM) averaged 6.22%. “The average 30-year fixed-rate mortgage is well below the year-to-date average of 6.62%, providing some sense of balance to the housing market,” said Sam Khater, Freddie Mac’s Chief Economist.  News FactsThe 30-year FRM averaged 6.22% as of December 11, 2025, up from last week when it averaged 6.19%. A year ago at this time, the 30-year FRM averaged 6.60%. The 15-year FRM averaged 5.54%, up from last week when it averaged 5.44%. A year ago at this time, the 15-year FRM averaged 5.84%.The PMMS® is focused on conventional, conforming,...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.